High Tower Advisors, LLC Ligand Pharmaceuticals Inc Transaction History

High Tower Advisors, LLC

  • $71.6 Billion
  • Q4 2024

A detailed history of High Tower Advisors, LLC transactions in Ligand Pharmaceuticals Inc stock. As of the latest transaction made, High Tower Advisors, LLC holds 5,542 shares of LGND stock, worth $638,382. This represents 0.0% of its overall portfolio holdings.

Number of Shares
5,542
Previous 5,142 7.78%
Holding current value
$638,382
Previous $515,000 15.15%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 07, 2025
BUY
$99.95 - $129.9 $39,980 - $51,960
400 Added 7.78%
5,542 $593,000
Q3 2024

Nov 14, 2024
BUY
$82.7 - $110.11 $21,998 - $29,289
266 Added 5.46%
5,142 $515,000
Q2 2024

Aug 13, 2024
BUY
$68.53 - $87.91 $17,954 - $23,032
262 Added 5.68%
4,876 $410,000
Q4 2023

Feb 12, 2024
BUY
$49.57 - $72.63 $2,329 - $3,413
47 Added 1.03%
4,614 $329,000
Q3 2023

Nov 08, 2023
BUY
$58.86 - $72.67 $98,590 - $121,722
1,675 Added 57.92%
4,567 $273,000
Q2 2023

Aug 14, 2023
BUY
$69.53 - $79.33 $8,482 - $9,678
122 Added 4.4%
2,892 $208,000
Q1 2023

May 11, 2023
BUY
$65.67 - $77.08 $181,905 - $213,511
2,770 New
2,770 $203,000
Q3 2022

Nov 09, 2022
BUY
$0.01 - $107.56 $0 - $322
3 Added 0.1%
2,967 $256,000
Q1 2022

May 12, 2022
SELL
$94.99 - $151.56 $7,314 - $11,670
-77 Reduced 2.53%
2,964 $333,000
Q4 2021

Feb 10, 2022
BUY
$127.69 - $165.85 $2,298 - $2,985
18 Added 0.6%
3,041 $469,000
Q3 2021

Nov 12, 2021
BUY
$102.33 - $144.73 $2,046 - $2,894
20 Added 0.67%
3,023 $419,000
Q2 2021

Aug 06, 2021
SELL
$113.03 - $155.64 $1,017 - $1,400
-9 Reduced 0.3%
3,003 $394,000
Q1 2021

May 10, 2021
SELL
$99.52 - $215.83 $7,264 - $15,755
-73 Reduced 2.37%
3,012 $458,000
Q4 2020

Feb 10, 2021
BUY
$80.55 - $106.05 $3,383 - $4,454
42 Added 1.38%
3,085 $308,000
Q3 2020

Nov 13, 2020
BUY
$89.56 - $126.72 $6,627 - $9,377
74 Added 2.49%
3,043 $290,000
Q2 2020

Aug 10, 2020
BUY
$68.28 - $123.65 $202,723 - $367,116
2,969 New
2,969 $332,000
Q4 2018

Feb 14, 2019
SELL
$128.36 - $272.13 $127,076 - $269,408
-990 Closed
0 $0
Q3 2018

Nov 09, 2018
BUY
$211.18 - $274.49 $209,068 - $271,745
990 New
990 $272,000
Q4 2017

Feb 14, 2018
SELL
$128.36 - $147.04 $574,282 - $657,856
-4,474 Closed
0 $0
Q3 2017

Nov 14, 2017
BUY
$120.91 - $137.94 $540,951 - $617,143
4,474
4,474 $613,000

Others Institutions Holding LGND

# of Institutions
262
Shares Held
18M
Call Options Held
26.8K
Put Options Held
9.3K
View Full List

About LIGAND PHARMACEUTICALS INC

LGND Quotes by TradingView
  • Ticker LGND
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 16,882,800
  • Market Cap $1.94B
  • Description
  • Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...
More about LGND
Track This Portfolio

Track High Tower Advisors, LLC Portfolio

Follow High Tower Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of High Tower Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on High Tower Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email